tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LGVN Stock Latest News

Longeveron announces type C meeting with FDA for Lomecel-B BLA
The FlyLongeveron announces type C meeting with FDA for Lomecel-B BLA
16d ago
LGVN
Longeveron price target lowered to $6 from $15 at Maxim
PremiumThe Fly
Longeveron price target lowered to $6 from $15 at Maxim
23d ago
LGVN
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
24d ago
LGVN
Longeveron reports Q2 EPS ($1.83), consensus (87c)
PremiumThe Fly
Longeveron reports Q2 EPS ($1.83), consensus (87c)
1M ago
LGVN
Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update
1M ago
LGVN
LGVN Earnings this Week: How Will it Perform?
PremiumPre-EarningsLGVN Earnings this Week: How Will it Perform?
1M ago
LGVN
Longeveron files to sell 2.57M shares of Class A common stock for holders
Premium
The Fly
Longeveron files to sell 2.57M shares of Class A common stock for holders
1M ago
LGVN
Longeveron price target lowered to $10 from $12 at H.C. Wainwright
Premium
The Fly
Longeveron price target lowered to $10 from $12 at H.C. Wainwright
2M ago
LGVN
Longeveron presents study results from CLEAR MIND Phase 2a trial
PremiumThe Fly
Longeveron presents study results from CLEAR MIND Phase 2a trial
2M ago
LGVN
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
PremiumPress Releases
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
2M ago
LGVN
Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2M ago
LGVN
Longeveron to sell 2.24M shares a $4.025 in registered direct offering
PremiumThe Fly
Longeveron to sell 2.24M shares a $4.025 in registered direct offering
2M ago
LGVN
Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress ReleasesLongeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2M ago
LGVN
Longeveron receives Fast Track Designation for Lomecel-B in mild Alzheimer’s
Premium
The Fly
Longeveron receives Fast Track Designation for Lomecel-B in mild Alzheimer’s
2M ago
LGVN
3 Penny Stocks to Watch Now, 7/11/24
Premium
Market News
3 Penny Stocks to Watch Now, 7/11/24
2M ago
ATNF
LGVN
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
PremiumPress Releases
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
2M ago
LGVN
Longeveron announces U.S. FDA granted RMAT designation to Lomecel-B
PremiumThe Fly
Longeveron announces U.S. FDA granted RMAT designation to Lomecel-B
2M ago
LGVN
Longeveron appoints Neha Motwani to board of directors
PremiumThe Fly
Longeveron appoints Neha Motwani to board of directors
2M ago
LGVN
Neha Motwani Elected to Longeveron® Board of Directors
PremiumPress Releases
Neha Motwani Elected to Longeveron® Board of Directors
2M ago
LGVN
Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
PremiumPress ReleasesGene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
2M ago
LGVN
Longeveron appoints Hajjar to board of directors
Premium
The Fly
Longeveron appoints Hajjar to board of directors
2M ago
LGVN
Longeveron files to sell 3.56M shares of Class A common stock for holders
Premium
The Fly
Longeveron files to sell 3.56M shares of Class A common stock for holders
3M ago
LGVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >